首页 › 基金 › Jupiter Topco LLC › MDGL
Jupiter Topco LLC 对 MDGL 的持仓历史
MADRIGAL PHARMACEUTICALS INC · 医疗保健
Jupiter Topco LLC 在 Q2 2026 的 13F 申报中披露持有 MDGL(MADRIGAL PHARMACEUTICALS INC)1,936,099 股,市值约 US$1.04B,约占其申报组合的 0.43%,在其申报持仓中市值排名第 44 位。 Jupiter Topco LLC 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Jupiter Topco LLC 对 MDGL 的持仓演变
Jupiter Topco LLC 于 Q2 2026 首次披露 MDGL 持仓:1,936,099 股(约 US$1.04B)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.94M | $1.04B | 新进 |
关于 MDGL 与 13F 数据
MDGL(MADRIGAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 MDGL,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), 骏利亨德森集团 (US$1.05B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MDGL 的基金
- BAKER BROS. ADVISORS LP 2.14M 股 · $1.15B · Q2 2026
- RTW INVESTMENTS, LP 1.99M 股 · $1.07B · Q2 2026
- 骏利亨德森集团 2.02M 股 · $1.05B · Q1 2026
- Avoro Capital Advisors LLC 1.83M 股 · $984.41M · Q2 2026
- 保尔森基金 1.34M 股 · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M 股 · $719.52M · Q2 2026
- ARMISTICE CAPITAL, LLC 288.00K 股 · $154.64M · Q2 2026
- Rock Springs Capital Management LP 175.00K 股 · $93.97M · Q2 2026
- Erste Asset Management GmbH 110.21K 股 · $58.11M · Q2 2026
更多关于 Jupiter Topco LLC
常见问题
How long has Jupiter Topco LLC held MDGL?
Jupiter Topco LLC has disclosed MDGL holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jupiter Topco LLC's current position in MDGL?
As of Q2 2026, Jupiter Topco LLC holds 1.94M shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $1.04B, representing 0.43% of its reported portfolio and ranking #44.
Has Jupiter Topco LLC been buying or selling MDGL?
In the latest 13F filing (Q2 2026), Jupiter Topco LLC newly opened its position in MDGL.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, 骏利亨德森集团, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.